Return to Alcohol Use After Liver Transplant: Who Is at Risk?

BACKGROUND Alcohol-associated liver disease remains the leading indication for liver transplant (LT), yet there has been limited analysis of what psychosocial factors correlate with biomarker-confirmed return to alcohol use in the post-LT setting. MATERIAL AND METHODS We conducted a single-center, retrospective, cohort study of all adult patients with alcohol-associated liver disease who received a liver transplant (LT) between 2016 and 2022. Medical records were queried for demographics, psychosocial variables, pre-LT sobriety duration, and 1-year post-LT mortality. Logistic regression and time-to-event analysis was used to correlate these factors with post-LT biomarker-confirmed return to alcohol use, defined as at least 1 positive urine ethyl glucuronide, urine ethyl sulfate, or serum phosphatidylethanol. RESULTS Of 194 LT recipients, 52 (27% of all patients, 42% of those tested) tested positive for 1 or more alcohol biomarkers at least once. Female sex and younger age, but not pre-LT sobriety duration, were identified as independent risk factors for biomarker-confirmed post-LT return to alcohol use. Survival analysis identified a shorter time to biomarker confirmed return to alcohol use for patients with <6 months (P<0.0001) and 6-12 months (P<0.0001) of pre-LT sobriety, compared with those with ≥12 months sobriety. However, patients with shorter pre-LT sobriety duration underwent biomarker testing significantly earlier following LT (P<0.0001). There was no difference in 1-year post-LT mortality between patients with <6 months and those with > 6-month pre-LT sobriety. CONCLUSIONS In this retrospective cohort study, we observed that 1-year mortality and biomarker-confirmed return to alcohol use outcomes were not affected by pre-LT sobriety duration, supporting evolving standards that favor individualized risk assessment over fixed abstinence periods.

Authors

Institutions

Publication Details

Journal
Annals of Transplantation
Published
2026-11-17
DOI
https://doi.org/10.12659/aot.952998
Primary Topic
Organ Transplantation Techniques and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Return to Alcohol Use After Liver Transplant: Who Is at Risk?

Ana Ivkovic, Heidi Yeh, Maria P. Diaz-Soto, Mladen Nisavic et al.
2 links
Annals of Transplantation
Organ Transplantation Techniques and Outcomes
article

Return to Alcohol Use After Liver Transplant: Who Is at Risk?

Ana Ivkovic, Heidi Yeh, Maria P. Diaz-Soto, Mladen Nisavic, Leigh Anne Dageforde, Eric M. Przybyszewski, Emily D. Bethea, Sofia G. Baptista, Kelly C. Hsu, Katherine C. Specht, Sienna D. Lila, Wei Zhang
article en

Abstract

BACKGROUND Alcohol-associated liver disease remains the leading indication for liver transplant (LT), yet there has been limited analysis of what psychosocial factors correlate with biomarker-confirmed return to alcohol use in the post-LT setting. MATERIAL AND METHODS We conducted a single-center, retrospective, cohort study of all adult patients with alcohol-associated liver disease who received a liver transplant (LT) between 2016 and 2022. Medical records were queried for demographics, psychosocial variables, pre-LT sobriety duration, and 1-year post-LT mortality. Logistic regression and time-to-event analysis was used to correlate these factors with post-LT biomarker-confirmed return to alcohol use, defined as at least 1 positive urine ethyl glucuronide, urine ethyl sulfate, or serum phosphatidylethanol. RESULTS Of 194 LT recipients, 52 (27% of all patients, 42% of those tested) tested positive for 1 or more alcohol biomarkers at least once. Female sex and younger age, but not pre-LT sobriety duration, were identified as independent risk factors for biomarker-confirmed post-LT return to alcohol use. Survival analysis identified a shorter time to biomarker confirmed return to alcohol use for patients with <6 months (P<0.0001) and 6-12 months (P<0.0001) of pre-LT sobriety, compared with those with ≥12 months sobriety. However, patients with shorter pre-LT sobriety duration underwent biomarker testing significantly earlier following LT (P<0.0001). There was no difference in 1-year post-LT mortality between patients with <6 months and those with > 6-month pre-LT sobriety. CONCLUSIONS In this retrospective cohort study, we observed that 1-year mortality and biomarker-confirmed return to alcohol use outcomes were not affected by pre-LT sobriety duration, supporting evolving standards that favor individualized risk assessment over fixed abstinence periods.

Annals of TransplantationVol. 31
Tufts University (US), Beth Israel Deaconess Medical Center (US), University of Massachusetts Chan Medical School (US), University of Washington (US), Massachusetts General Hospital (US), Vanderbilt University Medical Center (US)
Good health and well-being
Organ Transplantation Techniques and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon